Emerson Electric Co. (EMR) Stock Competitors & Peer Comparison
See (EMR) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMR | $137.37 | -2.50% | 79.6B | 32.88 | $4.32 | +1.54% |
| ETN | $393.42 | -6.60% | 162.6B | 40.93 | $10.23 | +1.02% |
| PH | $877.97 | +3.20% | 110B | 32.20 | $27.09 | +0.85% |
| CMI | $651.00 | -4.59% | 93.5B | 35.23 | $19.24 | +1.17% |
| JCI | $142.68 | -2.91% | 89.9B | 45.08 | $3.27 | +1.07% |
| ITW | $252.26 | +0.80% | 72.3B | 23.32 | $10.77 | +2.52% |
| PCAR | $116.46 | +1.82% | 62.1B | 25.12 | $4.70 | +2.31% |
| CARR | $66.58 | -1.48% | 56.9B | 45.69 | $1.50 | +1.36% |
| ROK | $443.43 | -3.96% | 51.4B | 47.93 | $9.64 | +1.18% |
| SYM | $43.43 | -8.01% | 30.4B | -592.62 | -$0.08 | N/A |
Stock Comparison
EMR vs ETN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, ETN has a market cap of 162.6B. Regarding current trading prices, EMR is priced at $137.37, while ETN trades at $393.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas ETN's P/E ratio is 40.93. In terms of profitability, EMR's ROE is +0.12%, compared to ETN's ROE of +0.21%. Regarding short-term risk, EMR is less volatile compared to ETN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ETN's competition here
EMR vs PH Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PH has a market cap of 110B. Regarding current trading prices, EMR is priced at $137.37, while PH trades at $877.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PH's P/E ratio is 32.20. In terms of profitability, EMR's ROE is +0.12%, compared to PH's ROE of +0.25%. Regarding short-term risk, EMR is less volatile compared to PH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PH's competition here
EMR vs CMI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CMI has a market cap of 93.5B. Regarding current trading prices, EMR is priced at $137.37, while CMI trades at $651.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CMI's P/E ratio is 35.23. In terms of profitability, EMR's ROE is +0.12%, compared to CMI's ROE of +0.22%. Regarding short-term risk, EMR is less volatile compared to CMI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CMI's competition here
EMR vs JCI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, JCI has a market cap of 89.9B. Regarding current trading prices, EMR is priced at $137.37, while JCI trades at $142.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas JCI's P/E ratio is 45.08. In terms of profitability, EMR's ROE is +0.12%, compared to JCI's ROE of +0.25%. Regarding short-term risk, EMR is less volatile compared to JCI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JCI's competition here
EMR vs ITW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, ITW has a market cap of 72.3B. Regarding current trading prices, EMR is priced at $137.37, while ITW trades at $252.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas ITW's P/E ratio is 23.32. In terms of profitability, EMR's ROE is +0.12%, compared to ITW's ROE of +0.97%. Regarding short-term risk, EMR is more volatile compared to ITW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ITW's competition here
EMR vs PCAR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PCAR has a market cap of 62.1B. Regarding current trading prices, EMR is priced at $137.37, while PCAR trades at $116.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PCAR's P/E ratio is 25.12. In terms of profitability, EMR's ROE is +0.12%, compared to PCAR's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to PCAR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check PCAR's competition here
EMR vs CARR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CARR has a market cap of 56.9B. Regarding current trading prices, EMR is priced at $137.37, while CARR trades at $66.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CARR's P/E ratio is 45.69. In terms of profitability, EMR's ROE is +0.12%, compared to CARR's ROE of +0.09%. Regarding short-term risk, EMR is more volatile compared to CARR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CARR's competition here
EMR vs ROK Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, ROK has a market cap of 51.4B. Regarding current trading prices, EMR is priced at $137.37, while ROK trades at $443.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas ROK's P/E ratio is 47.93. In terms of profitability, EMR's ROE is +0.12%, compared to ROK's ROE of +0.30%. Regarding short-term risk, EMR is less volatile compared to ROK. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ROK's competition here
EMR vs SYM Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SYM has a market cap of 30.4B. Regarding current trading prices, EMR is priced at $137.37, while SYM trades at $43.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SYM's P/E ratio is -592.62. In terms of profitability, EMR's ROE is +0.12%, compared to SYM's ROE of -0.01%. Regarding short-term risk, EMR is less volatile compared to SYM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SYM's competition here
EMR vs DOV Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, DOV has a market cap of 28.7B. Regarding current trading prices, EMR is priced at $137.37, while DOV trades at $214.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas DOV's P/E ratio is 26.65. In terms of profitability, EMR's ROE is +0.12%, compared to DOV's ROE of +0.15%. Regarding short-term risk, EMR is more volatile compared to DOV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check DOV's competition here
EMR vs IR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, IR has a market cap of 28.2B. Regarding current trading prices, EMR is priced at $137.37, while IR trades at $71.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas IR's P/E ratio is 48.65. In terms of profitability, EMR's ROE is +0.12%, compared to IR's ROE of +0.06%. Regarding short-term risk, EMR is more volatile compared to IR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check IR's competition here
EMR vs OTIS Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, OTIS has a market cap of 26.8B. Regarding current trading prices, EMR is priced at $137.37, while OTIS trades at $70.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas OTIS's P/E ratio is 18.58. In terms of profitability, EMR's ROE is +0.12%, compared to OTIS's ROE of -0.27%. Regarding short-term risk, EMR is more volatile compared to OTIS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check OTIS's competition here
EMR vs XYL Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, XYL has a market cap of 26.2B. Regarding current trading prices, EMR is priced at $137.37, while XYL trades at $109.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas XYL's P/E ratio is 27.47. In terms of profitability, EMR's ROE is +0.12%, compared to XYL's ROE of +0.09%. Regarding short-term risk, EMR is more volatile compared to XYL. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check XYL's competition here
EMR vs P Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, P has a market cap of 26.1B. Regarding current trading prices, EMR is priced at $137.37, while P trades at $71.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas P's P/E ratio is 118.97. In terms of profitability, EMR's ROE is +0.12%, compared to P's ROE of +0.14%. Regarding short-term risk, EMR is less volatile compared to P. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check P's competition here
EMR vs MAIR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, MAIR has a market cap of 21.7B. Regarding current trading prices, EMR is priced at $137.37, while MAIR trades at $40.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas MAIR's P/E ratio is 123.94. In terms of profitability, EMR's ROE is +0.12%, compared to MAIR's ROE of +0.00%. Regarding short-term risk, EMR is less volatile compared to MAIR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MAIR's competition here
EMR vs FTV Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, FTV has a market cap of 18.7B. Regarding current trading prices, EMR is priced at $137.37, while FTV trades at $60.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas FTV's P/E ratio is 36.16. In terms of profitability, EMR's ROE is +0.12%, compared to FTV's ROE of +0.07%. Regarding short-term risk, EMR is more volatile compared to FTV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check FTV's competition here
EMR vs ITT Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, ITT has a market cap of 17.3B. Regarding current trading prices, EMR is priced at $137.37, while ITT trades at $191.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas ITT's P/E ratio is 34.09. In terms of profitability, EMR's ROE is +0.12%, compared to ITT's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to ITT. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ITT's competition here
EMR vs GNRC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GNRC has a market cap of 16.4B. Regarding current trading prices, EMR is priced at $137.37, while GNRC trades at $257.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GNRC's P/E ratio is 86.92. In terms of profitability, EMR's ROE is +0.12%, compared to GNRC's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to GNRC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GNRC's competition here
EMR vs IEX Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, IEX has a market cap of 16B. Regarding current trading prices, EMR is priced at $137.37, while IEX trades at $215.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas IEX's P/E ratio is 31.99. In terms of profitability, EMR's ROE is +0.12%, compared to IEX's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to IEX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check IEX's competition here
EMR vs NDSN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, NDSN has a market cap of 16B. Regarding current trading prices, EMR is priced at $137.37, while NDSN trades at $282.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas NDSN's P/E ratio is 30.64. In terms of profitability, EMR's ROE is +0.12%, compared to NDSN's ROE of +0.17%. Regarding short-term risk, EMR is more volatile compared to NDSN. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check NDSN's competition here
EMR vs RRX Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, RRX has a market cap of 14.2B. Regarding current trading prices, EMR is priced at $137.37, while RRX trades at $203.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas RRX's P/E ratio is 49.60. In terms of profitability, EMR's ROE is +0.12%, compared to RRX's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to RRX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check RRX's competition here
EMR vs GGG Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GGG has a market cap of 12.3B. Regarding current trading prices, EMR is priced at $137.37, while GGG trades at $74.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GGG's P/E ratio is 24.28. In terms of profitability, EMR's ROE is +0.12%, compared to GGG's ROE of +0.20%. Regarding short-term risk, EMR is more volatile compared to GGG. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GGG's competition here
EMR vs SPXC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SPXC has a market cap of 11.8B. Regarding current trading prices, EMR is priced at $137.37, while SPXC trades at $226.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SPXC's P/E ratio is 45.04. In terms of profitability, EMR's ROE is +0.12%, compared to SPXC's ROE of +0.13%. Regarding short-term risk, EMR is less volatile compared to SPXC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SPXC's competition here
EMR vs PNR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PNR has a market cap of 11.8B. Regarding current trading prices, EMR is priced at $137.37, while PNR trades at $72.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PNR's P/E ratio is 18.31. In terms of profitability, EMR's ROE is +0.12%, compared to PNR's ROE of +0.18%. Regarding short-term risk, EMR is more volatile compared to PNR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check PNR's competition here
EMR vs CR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CR has a market cap of 10.9B. Regarding current trading prices, EMR is priced at $137.37, while CR trades at $187.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CR's P/E ratio is 34.41. In terms of profitability, EMR's ROE is +0.12%, compared to CR's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to CR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CR's competition here
EMR vs WTS Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, WTS has a market cap of 10.5B. Regarding current trading prices, EMR is priced at $137.37, while WTS trades at $313.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas WTS's P/E ratio is 28.85. In terms of profitability, EMR's ROE is +0.12%, compared to WTS's ROE of +0.18%. Regarding short-term risk, EMR is more volatile compared to WTS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check WTS's competition here
EMR vs GTLS Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GTLS has a market cap of 9.9B. Regarding current trading prices, EMR is priced at $137.37, while GTLS trades at $207.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GTLS's P/E ratio is -203.46. In terms of profitability, EMR's ROE is +0.12%, compared to GTLS's ROE of -0.01%. Regarding short-term risk, EMR is more volatile compared to GTLS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTLS's competition here
EMR vs DCI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, DCI has a market cap of 9.7B. Regarding current trading prices, EMR is priced at $137.37, while DCI trades at $82.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas DCI's P/E ratio is 22.66. In terms of profitability, EMR's ROE is +0.12%, compared to DCI's ROE of +0.28%. Regarding short-term risk, EMR is more volatile compared to DCI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check DCI's competition here
EMR vs FLS Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, FLS has a market cap of 9.6B. Regarding current trading prices, EMR is priced at $137.37, while FLS trades at $72.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas FLS's P/E ratio is 27.73. In terms of profitability, EMR's ROE is +0.12%, compared to FLS's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to FLS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check FLS's competition here
EMR vs OSK Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, OSK has a market cap of 8.3B. Regarding current trading prices, EMR is priced at $137.37, while OSK trades at $131.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas OSK's P/E ratio is 14.82. In terms of profitability, EMR's ROE is +0.12%, compared to OSK's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to OSK. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check OSK's competition here
EMR vs AOS Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, AOS has a market cap of 8B. Regarding current trading prices, EMR is priced at $137.37, while AOS trades at $57.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas AOS's P/E ratio is 15.20. In terms of profitability, EMR's ROE is +0.12%, compared to AOS's ROE of +0.28%. Regarding short-term risk, EMR is more volatile compared to AOS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AOS's competition here
EMR vs MIDD Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, MIDD has a market cap of 7B. Regarding current trading prices, EMR is priced at $137.37, while MIDD trades at $154.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas MIDD's P/E ratio is 21.36. In terms of profitability, EMR's ROE is +0.12%, compared to MIDD's ROE of -0.14%. Regarding short-term risk, EMR is less volatile compared to MIDD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIDD's competition here
EMR vs NPO Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, NPO has a market cap of 6.7B. Regarding current trading prices, EMR is priced at $137.37, while NPO trades at $310.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas NPO's P/E ratio is 154.03. In terms of profitability, EMR's ROE is +0.12%, compared to NPO's ROE of +0.03%. Regarding short-term risk, EMR is more volatile compared to NPO. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check NPO's competition here
EMR vs GTES Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GTES has a market cap of 6.6B. Regarding current trading prices, EMR is priced at $137.37, while GTES trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GTES's P/E ratio is 27.48. In terms of profitability, EMR's ROE is +0.12%, compared to GTES's ROE of +0.07%. Regarding short-term risk, EMR is more volatile compared to GTES. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTES's competition here
EMR vs JBTM Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, JBTM has a market cap of 6.5B. Regarding current trading prices, EMR is priced at $137.37, while JBTM trades at $124.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas JBTM's P/E ratio is 38.55. In terms of profitability, EMR's ROE is +0.12%, compared to JBTM's ROE of +0.04%. Regarding short-term risk, EMR is more volatile compared to JBTM. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check JBTM's competition here
EMR vs PSN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PSN has a market cap of 6.5B. Regarding current trading prices, EMR is priced at $137.37, while PSN trades at $58.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PSN's P/E ratio is 29.00. In terms of profitability, EMR's ROE is +0.12%, compared to PSN's ROE of +0.09%. Regarding short-term risk, EMR is less volatile compared to PSN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PSN's competition here
EMR vs AEBIV Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, AEBIV has a market cap of 6.5B. Regarding current trading prices, EMR is priced at $137.37, while AEBIV trades at $83.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas AEBIV's P/E ratio is 213.49. In terms of profitability, EMR's ROE is +0.12%, compared to AEBIV's ROE of +0.00%. Regarding short-term risk, EMR is more volatile compared to AEBIV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AEBIV's competition here
EMR vs CSWI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CSWI has a market cap of 4.9B. Regarding current trading prices, EMR is priced at $137.37, while CSWI trades at $305.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CSWI's P/E ratio is 36.36. In terms of profitability, EMR's ROE is +0.12%, compared to CSWI's ROE of +0.10%. Regarding short-term risk, EMR is more volatile compared to CSWI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CSWI's competition here
EMR vs MIR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, MIR has a market cap of 4.5B. Regarding current trading prices, EMR is priced at $137.37, while MIR trades at $16.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas MIR's P/E ratio is 182.50. In terms of profitability, EMR's ROE is +0.12%, compared to MIR's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to MIR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIR's competition here
EMR vs CSW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CSW has a market cap of 4.4B. Regarding current trading prices, EMR is priced at $137.37, while CSW trades at $264.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CSW's P/E ratio is 40.27. In terms of profitability, EMR's ROE is +0.12%, compared to CSW's ROE of +0.10%. Regarding short-term risk, EMR is more volatile compared to CSW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CSW's competition here
EMR vs FELE Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, FELE has a market cap of 4.3B. Regarding current trading prices, EMR is priced at $137.37, while FELE trades at $98.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas FELE's P/E ratio is 29.54. In terms of profitability, EMR's ROE is +0.12%, compared to FELE's ROE of +0.11%. Regarding short-term risk, EMR is more volatile compared to FELE. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check FELE's competition here
EMR vs XMTR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, XMTR has a market cap of 4.2B. Regarding current trading prices, EMR is priced at $137.37, while XMTR trades at $79.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas XMTR's P/E ratio is -81.08. In terms of profitability, EMR's ROE is +0.12%, compared to XMTR's ROE of -0.19%. Regarding short-term risk, EMR is less volatile compared to XMTR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XMTR's competition here
EMR vs AIMC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, AIMC has a market cap of 4.1B. Regarding current trading prices, EMR is priced at $137.37, while AIMC trades at $61.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas AIMC's P/E ratio is 31.95. In terms of profitability, EMR's ROE is +0.12%, compared to AIMC's ROE of +0.06%. Regarding short-term risk, EMR is more volatile compared to AIMC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AIMC's competition here
EMR vs JBT Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, JBT has a market cap of 4B. Regarding current trading prices, EMR is priced at $137.37, while JBT trades at $125.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas JBT's P/E ratio is 28.04. In terms of profitability, EMR's ROE is +0.12%, compared to JBT's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to JBT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JBT's competition here
EMR vs MWA Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, MWA has a market cap of 3.9B. Regarding current trading prices, EMR is priced at $137.37, while MWA trades at $25.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas MWA's P/E ratio is 19.01. In terms of profitability, EMR's ROE is +0.12%, compared to MWA's ROE of +0.21%. Regarding short-term risk, EMR is more volatile compared to MWA. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check MWA's competition here
EMR vs SXI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SXI has a market cap of 3.6B. Regarding current trading prices, EMR is priced at $137.37, while SXI trades at $287.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SXI's P/E ratio is 36.19. In terms of profitability, EMR's ROE is +0.12%, compared to SXI's ROE of +0.14%. Regarding short-term risk, EMR is less volatile compared to SXI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SXI's competition here
EMR vs KAI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, KAI has a market cap of 3.6B. Regarding current trading prices, EMR is priced at $137.37, while KAI trades at $290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas KAI's P/E ratio is 34.62. In terms of profitability, EMR's ROE is +0.12%, compared to KAI's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to KAI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check KAI's competition here
EMR vs GTLS-PB Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GTLS-PB has a market cap of 3.2B. Regarding current trading prices, EMR is priced at $137.37, while GTLS-PB trades at $72.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GTLS-PB's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to GTLS-PB's ROE of -0.01%. Regarding short-term risk, EMR is more volatile compared to GTLS-PB. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTLS-PB's competition here
EMR vs HLIO Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HLIO has a market cap of 2.8B. Regarding current trading prices, EMR is priced at $137.37, while HLIO trades at $80.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HLIO's P/E ratio is 47.21. In terms of profitability, EMR's ROE is +0.12%, compared to HLIO's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to HLIO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HLIO's competition here
EMR vs ATS Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, ATS has a market cap of 2.8B. Regarding current trading prices, EMR is priced at $137.37, while ATS trades at $26.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas ATS's P/E ratio is 53.28. In terms of profitability, EMR's ROE is +0.12%, compared to ATS's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to ATS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ATS's competition here
EMR vs BW-PA Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, BW-PA has a market cap of 2.6B. Regarding current trading prices, EMR is priced at $137.37, while BW-PA trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas BW-PA's P/E ratio is 80.66. In terms of profitability, EMR's ROE is +0.12%, compared to BW-PA's ROE of +0.61%. Regarding short-term risk, EMR is more volatile compared to BW-PA. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check BW-PA's competition here
EMR vs MIR-WT Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, MIR-WT has a market cap of 2.4B. Regarding current trading prices, EMR is priced at $137.37, while MIR-WT trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas MIR-WT's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to MIR-WT's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to MIR-WT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIR-WT's competition here
EMR vs HI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HI has a market cap of 2.3B. Regarding current trading prices, EMR is priced at $137.37, while HI trades at $31.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HI's P/E ratio is 65.27. In terms of profitability, EMR's ROE is +0.12%, compared to HI's ROE of +0.03%. Regarding short-term risk, EMR is more volatile compared to HI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check HI's competition here
EMR vs AMSC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, AMSC has a market cap of 2.2B. Regarding current trading prices, EMR is priced at $137.37, while AMSC trades at $41.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas AMSC's P/E ratio is 15.21. In terms of profitability, EMR's ROE is +0.12%, compared to AMSC's ROE of +0.30%. Regarding short-term risk, EMR is less volatile compared to AMSC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check AMSC's competition here
EMR vs CYD Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CYD has a market cap of 2.2B. Regarding current trading prices, EMR is priced at $137.37, while CYD trades at $55.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CYD's P/E ratio is 27.46. In terms of profitability, EMR's ROE is +0.12%, compared to CYD's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to CYD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CYD's competition here
EMR vs CXT Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CXT has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $137.37, while CXT trades at $36.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CXT's P/E ratio is 16.70. In terms of profitability, EMR's ROE is +0.12%, compared to CXT's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to CXT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CXT's competition here
EMR vs BW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, BW has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $137.37, while BW trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas BW's P/E ratio is -21.19. In terms of profitability, EMR's ROE is +0.12%, compared to BW's ROE of +0.61%. Regarding short-term risk, EMR is less volatile compared to BW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BW's competition here
EMR vs CFX Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CFX has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $137.37, while CFX trades at $39.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CFX's P/E ratio is 28.55. In terms of profitability, EMR's ROE is +0.12%, compared to CFX's ROE of -0.60%. Regarding short-term risk, EMR is less volatile compared to CFX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CFX's competition here
EMR vs SHPW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SHPW has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $137.37, while SHPW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SHPW's P/E ratio is -0.05. In terms of profitability, EMR's ROE is +0.12%, compared to SHPW's ROE of -0.93%. Regarding short-term risk, EMR is more volatile compared to SHPW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check SHPW's competition here
EMR vs GRC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GRC has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $137.37, while GRC trades at $77.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GRC's P/E ratio is 34.88. In terms of profitability, EMR's ROE is +0.12%, compared to GRC's ROE of +0.14%. Regarding short-term risk, EMR is more volatile compared to GRC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GRC's competition here
EMR vs THR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, THR has a market cap of 2B. Regarding current trading prices, EMR is priced at $137.37, while THR trades at $61.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas THR's P/E ratio is 44.96. In terms of profitability, EMR's ROE is +0.12%, compared to THR's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to THR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check THR's competition here
EMR vs BLDP Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, BLDP has a market cap of 1.8B. Regarding current trading prices, EMR is priced at $137.37, while BLDP trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas BLDP's P/E ratio is -22.48. In terms of profitability, EMR's ROE is +0.12%, compared to BLDP's ROE of -0.13%. Regarding short-term risk, EMR is less volatile compared to BLDP. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BLDP's competition here
EMR vs EPAC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, EPAC has a market cap of 1.8B. Regarding current trading prices, EMR is priced at $137.37, while EPAC trades at $33.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas EPAC's P/E ratio is 20.88. In terms of profitability, EMR's ROE is +0.12%, compared to EPAC's ROE of +0.20%. Regarding short-term risk, EMR is more volatile compared to EPAC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check EPAC's competition here
EMR vs TNC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, TNC has a market cap of 1.4B. Regarding current trading prices, EMR is priced at $137.37, while TNC trades at $83.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas TNC's P/E ratio is 50.44. In terms of profitability, EMR's ROE is +0.12%, compared to TNC's ROE of +0.05%. Regarding short-term risk, EMR is more volatile compared to TNC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check TNC's competition here
EMR vs GHM Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GHM has a market cap of 1.2B. Regarding current trading prices, EMR is priced at $137.37, while GHM trades at $105.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GHM's P/E ratio is 79.84. In terms of profitability, EMR's ROE is +0.12%, compared to GHM's ROE of +0.12%. Regarding short-term risk, EMR is less volatile compared to GHM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GHM's competition here
EMR vs CIR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CIR has a market cap of 1.1B. Regarding current trading prices, EMR is priced at $137.37, while CIR trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CIR's P/E ratio is 38.89. In terms of profitability, EMR's ROE is +0.12%, compared to CIR's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to CIR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CIR's competition here
EMR vs NNE Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, NNE has a market cap of 1.1B. Regarding current trading prices, EMR is priced at $137.37, while NNE trades at $22.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas NNE's P/E ratio is -38.47. In terms of profitability, EMR's ROE is +0.12%, compared to NNE's ROE of -0.08%. Regarding short-term risk, EMR is less volatile compared to NNE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NNE's competition here
EMR vs PSIX Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PSIX has a market cap of 926.2M. Regarding current trading prices, EMR is priced at $137.37, while PSIX trades at $36.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PSIX's P/E ratio is 9.07. In terms of profitability, EMR's ROE is +0.12%, compared to PSIX's ROE of +0.62%. Regarding short-term risk, EMR is less volatile compared to PSIX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PSIX's competition here
EMR vs KRNT Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, KRNT has a market cap of 739.6M. Regarding current trading prices, EMR is priced at $137.37, while KRNT trades at $15.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas KRNT's P/E ratio is -42.00. In terms of profitability, EMR's ROE is +0.12%, compared to KRNT's ROE of -0.02%. Regarding short-term risk, EMR is less volatile compared to KRNT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check KRNT's competition here
EMR vs SERV Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SERV has a market cap of 560.1M. Regarding current trading prices, EMR is priced at $137.37, while SERV trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SERV's P/E ratio is -4.10. In terms of profitability, EMR's ROE is +0.12%, compared to SERV's ROE of -0.47%. Regarding short-term risk, EMR is less volatile compared to SERV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SERV's competition here
EMR vs RR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, RR has a market cap of 501.4M. Regarding current trading prices, EMR is priced at $137.37, while RR trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas RR's P/E ratio is -21.00. In terms of profitability, EMR's ROE is +0.12%, compared to RR's ROE of -0.11%. Regarding short-term risk, EMR is less volatile compared to RR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check RR's competition here
EMR vs PKOH Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PKOH has a market cap of 476.9M. Regarding current trading prices, EMR is priced at $137.37, while PKOH trades at $31.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PKOH's P/E ratio is 18.93. In terms of profitability, EMR's ROE is +0.12%, compared to PKOH's ROE of +0.06%. Regarding short-term risk, EMR is more volatile compared to PKOH. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check PKOH's competition here
EMR vs LXFR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, LXFR has a market cap of 474M. Regarding current trading prices, EMR is priced at $137.37, while LXFR trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas LXFR's P/E ratio is 41.79. In terms of profitability, EMR's ROE is +0.12%, compared to LXFR's ROE of +0.03%. Regarding short-term risk, EMR is less volatile compared to LXFR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check LXFR's competition here
EMR vs XE Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, XE has a market cap of 472.8M. Regarding current trading prices, EMR is priced at $137.37, while XE trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas XE's P/E ratio is -43.74. In terms of profitability, EMR's ROE is +0.12%, compared to XE's ROE of -0.93%. Regarding short-term risk, EMR is less volatile compared to XE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XE's competition here
EMR vs AIRJ Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, AIRJ has a market cap of 417.6M. Regarding current trading prices, EMR is priced at $137.37, while AIRJ trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas AIRJ's P/E ratio is -4.99. In terms of profitability, EMR's ROE is +0.12%, compared to AIRJ's ROE of -0.27%. Regarding short-term risk, EMR is less volatile compared to AIRJ. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check AIRJ's competition here
EMR vs BGRY Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, BGRY has a market cap of 340.7M. Regarding current trading prices, EMR is priced at $137.37, while BGRY trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas BGRY's P/E ratio is -2.86. In terms of profitability, EMR's ROE is +0.12%, compared to BGRY's ROE of -0.96%. Regarding short-term risk, EMR is more volatile compared to BGRY. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check BGRY's competition here
EMR vs OFLX Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, OFLX has a market cap of 303.9M. Regarding current trading prices, EMR is priced at $137.37, while OFLX trades at $30.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas OFLX's P/E ratio is 22.64. In terms of profitability, EMR's ROE is +0.12%, compared to OFLX's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to OFLX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check OFLX's competition here
EMR vs TWIN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, TWIN has a market cap of 270.6M. Regarding current trading prices, EMR is priced at $137.37, while TWIN trades at $19.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas TWIN's P/E ratio is 10.09. In terms of profitability, EMR's ROE is +0.12%, compared to TWIN's ROE of +0.15%. Regarding short-term risk, EMR is less volatile compared to TWIN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TWIN's competition here
EMR vs SHMD Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SHMD has a market cap of 268.3M. Regarding current trading prices, EMR is priced at $137.37, while SHMD trades at $4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SHMD's P/E ratio is -2.86. In terms of profitability, EMR's ROE is +0.12%, compared to SHMD's ROE of +0.74%. Regarding short-term risk, EMR is less volatile compared to SHMD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SHMD's competition here
EMR vs HUHU Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HUHU has a market cap of 211.6M. Regarding current trading prices, EMR is priced at $137.37, while HUHU trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HUHU's P/E ratio is -11.07. In terms of profitability, EMR's ROE is +0.12%, compared to HUHU's ROE of -0.34%. Regarding short-term risk, EMR is less volatile compared to HUHU. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HUHU's competition here
EMR vs TAYD Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, TAYD has a market cap of 169.2M. Regarding current trading prices, EMR is priced at $137.37, while TAYD trades at $52.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas TAYD's P/E ratio is 16.64. In terms of profitability, EMR's ROE is +0.12%, compared to TAYD's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to TAYD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TAYD's competition here
EMR vs NPWR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, NPWR has a market cap of 164.4M. Regarding current trading prices, EMR is priced at $137.37, while NPWR trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas NPWR's P/E ratio is -0.31. In terms of profitability, EMR's ROE is +0.12%, compared to NPWR's ROE of -1.60%. Regarding short-term risk, EMR is less volatile compared to NPWR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NPWR's competition here
EMR vs HURC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HURC has a market cap of 110.4M. Regarding current trading prices, EMR is priced at $137.37, while HURC trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HURC's P/E ratio is -7.75. In terms of profitability, EMR's ROE is +0.12%, compared to HURC's ROE of -0.07%. Regarding short-term risk, EMR is less volatile compared to HURC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HURC's competition here
EMR vs AIRJW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, AIRJW has a market cap of 102.6M. Regarding current trading prices, EMR is priced at $137.37, while AIRJW trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas AIRJW's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to AIRJW's ROE of -0.27%. Regarding short-term risk, EMR is less volatile compared to AIRJW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check AIRJW's competition here
EMR vs BWEN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, BWEN has a market cap of 97.8M. Regarding current trading prices, EMR is priced at $137.37, while BWEN trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas BWEN's P/E ratio is 18.17. In terms of profitability, EMR's ROE is +0.12%, compared to BWEN's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to BWEN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BWEN's competition here
EMR vs HDRN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HDRN has a market cap of 96.7M. Regarding current trading prices, EMR is priced at $137.37, while HDRN trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HDRN's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to HDRN's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to HDRN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HDRN's competition here
EMR vs SHMDW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, SHMDW has a market cap of 74.9M. Regarding current trading prices, EMR is priced at $137.37, while SHMDW trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas SHMDW's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to SHMDW's ROE of +0.74%. Regarding short-term risk, EMR is less volatile compared to SHMDW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SHMDW's competition here
EMR vs PYR Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, PYR has a market cap of 68M. Regarding current trading prices, EMR is priced at $137.37, while PYR trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas PYR's P/E ratio is -3.17. In terms of profitability, EMR's ROE is +0.12%, compared to PYR's ROE of -1.12%. Regarding short-term risk, EMR is less volatile compared to PYR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PYR's competition here
EMR vs LASE Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, LASE has a market cap of 62M. Regarding current trading prices, EMR is priced at $137.37, while LASE trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas LASE's P/E ratio is -3.55. In terms of profitability, EMR's ROE is +0.12%, compared to LASE's ROE of -6.81%. Regarding short-term risk, EMR is less volatile compared to LASE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check LASE's competition here
EMR vs CVV Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CVV has a market cap of 41.8M. Regarding current trading prices, EMR is priced at $137.37, while CVV trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CVV's P/E ratio is -13.38. In terms of profitability, EMR's ROE is +0.12%, compared to CVV's ROE of -0.15%. Regarding short-term risk, EMR is less volatile compared to CVV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CVV's competition here
EMR vs XCH Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, XCH has a market cap of 38.5M. Regarding current trading prices, EMR is priced at $137.37, while XCH trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas XCH's P/E ratio is -1.53. In terms of profitability, EMR's ROE is +0.12%, compared to XCH's ROE of -1.37%. Regarding short-term risk, EMR is more volatile compared to XCH. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check XCH's competition here
EMR vs BURU Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, BURU has a market cap of 20.8M. Regarding current trading prices, EMR is priced at $137.37, while BURU trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas BURU's P/E ratio is -0.20. In terms of profitability, EMR's ROE is +0.12%, compared to BURU's ROE of +2.27%. Regarding short-term risk, EMR is less volatile compared to BURU. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BURU's competition here
EMR vs GTEC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, GTEC has a market cap of 16.5M. Regarding current trading prices, EMR is priced at $137.37, while GTEC trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas GTEC's P/E ratio is 2.64. In terms of profitability, EMR's ROE is +0.12%, compared to GTEC's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to GTEC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GTEC's competition here
EMR vs WFF Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, WFF has a market cap of 10.2M. Regarding current trading prices, EMR is priced at $137.37, while WFF trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas WFF's P/E ratio is -2.09. In terms of profitability, EMR's ROE is +0.12%, compared to WFF's ROE of -1.27%. Regarding short-term risk, EMR is less volatile compared to WFF. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check WFF's competition here
EMR vs HDRNW Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HDRNW has a market cap of 10.1M. Regarding current trading prices, EMR is priced at $137.37, while HDRNW trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HDRNW's P/E ratio is 3.77. In terms of profitability, EMR's ROE is +0.12%, compared to HDRNW's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to HDRNW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HDRNW's competition here
EMR vs HCAI Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, HCAI has a market cap of 7.7M. Regarding current trading prices, EMR is priced at $137.37, while HCAI trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas HCAI's P/E ratio is -0.01. In terms of profitability, EMR's ROE is +0.12%, compared to HCAI's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to HCAI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HCAI's competition here
EMR vs JCSE Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, JCSE has a market cap of 7.3M. Regarding current trading prices, EMR is priced at $137.37, while JCSE trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas JCSE's P/E ratio is 2.89. In terms of profitability, EMR's ROE is +0.12%, compared to JCSE's ROE of +0.13%. Regarding short-term risk, EMR is less volatile compared to JCSE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JCSE's competition here
EMR vs CGRN Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, CGRN has a market cap of 6.8M. Regarding current trading prices, EMR is priced at $137.37, while CGRN trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas CGRN's P/E ratio is -0.42. In terms of profitability, EMR's ROE is +0.12%, compared to CGRN's ROE of -0.30%. Regarding short-term risk, EMR is less volatile compared to CGRN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CGRN's competition here
EMR vs TPIC Comparison June 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 79.6B. In comparison, TPIC has a market cap of 6.2M. Regarding current trading prices, EMR is priced at $137.37, while TPIC trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 32.88, whereas TPIC's P/E ratio is -0.03. In terms of profitability, EMR's ROE is +0.12%, compared to TPIC's ROE of +0.89%. Regarding short-term risk, EMR is less volatile compared to TPIC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TPIC's competition here